The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in older patients with high-risk/secondary AML who achieved remission with CPX-351 versus 7+3 but did not undergo transplant: Phase 3 exploratory analysis.
 
Tara L. Lin
Honoraria - Jazz Pharmaceuticals; Pfizer
Consulting or Advisory Role - Pfizer
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celator (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Imago Pharma (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Mateon Therapeutics (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Robert J Ryan
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Stefan Faderl
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Novartis; NS Pharma; Pfizer
Travel, Accommodations, Expenses - Celgene; Novartis